F R Ellis
Overview
Explore the profile of F R Ellis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
782
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hopkins P, Ruffert H, Snoeck M, Girard T, Glahn K, Ellis F, et al.
Br J Anaesth
. 2015 Jul;
115(4):531-9.
PMID: 26188342
It is 30 yr since the British Journal of Anaesthesia published the first consensus protocol for the laboratory diagnosis of malignant hyperthermia susceptibility from the European Malignant Hyperthermia Group. This...
2.
Glahn K, Ellis F, Halsall P, Muller C, Snoeck M, Urwyler A, et al.
Br J Anaesth
. 2010 Sep;
105(4):417-20.
PMID: 20837722
Survival from a malignant hyperthermia (MH) crisis is highly dependent on early recognition and prompt action. MH crises are very rare and an increasing use of total i.v. anaesthesia is...
3.
Fehily A, Bowey O, Ellis F, MEADE B, Dickerson J
Neurochem Int
. 2010 May;
3(1):37-42.
PMID: 20487806
Patients suffering from endogenous depression had significantly greater proportions of long chain polyunsaturated fatty acids (LCP), docosahexaenoic acid (22:6?3) and eicosapentaenoic acid (20:5?3), and a reduced proportion of linoleic acid...
4.
Robinson R, Curran J, Ellis F, Halsall P, Hall W, Hopkins P, et al.
Ann Hum Genet
. 2001 Jun;
64(Pt 4):307-20.
PMID: 11415515
Malignant hyperthermia (MH) is a potentially lethal disorder triggered in susceptible individuals on exposure to common anaesthetic agents. Crises reflect the consequences of disturbed skeletal muscle calcium homeostasis. MH is...
5.
Curran J, Hall W, Halsall P, Hopkins P, Iles D, Markham A, et al.
Br J Anaesth
. 2000 Jan;
83(2):217-22.
PMID: 10618932
Malignant hyperthermia (MH) is an autosomal dominant disorder presenting under general anaesthesia. It is occasionally associated with a myopathy, central core disease (CCD), named after its predominant histochemical characteristic. The...
6.
Robinson R, Curran J, Hall W, Halsall P, Hopkins P, Markham A, et al.
J Med Genet
. 1998 Apr;
35(3):196-201.
PMID: 9541102
Malignant hyperthermia (MH) is an autosomal dominant genetic condition that presents in susceptible people undergoing general anaesthesia. The clinical disorder is a major cause of anaesthetic morbidity and mortality. The...
7.
Ording H, Brancadoro V, Cozzolino S, Ellis F, Glauber V, Gonano E, et al.
Acta Anaesthesiol Scand
. 1997 Oct;
41(8):955-66.
PMID: 9311391
Background: Determination of sensitivity and specificity of the in vitro contracture test (IVCT) for malignant hyperthermia (MH) susceptibility using the European MH Group (EMHG) protocol has been performed in some...
8.
Adeokun A, West S, Ellis F, Halsall P, Hopkins P, Foroughmand A, et al.
Am J Hum Genet
. 1997 Apr;
60(4):833-41.
PMID: 9106529
A single base change in the RYR1 gene encoding the skeletal muscle ryanodine receptor (calcium-sensitive calcium-release channel of the sarcoplasmic reticulum), resulting in the substitution of G1021 by A, has...
9.
Hopkins P, Ellis F, Halsall P, Stewart A
Anesth Analg
. 1997 Mar;
84(3):648-56.
PMID: 9052318
An objective estimate of the likelihood of correct designation of malignant hyperthermia (MH) susceptibility from in vitro contracture test (IVCT) results is essential if genetic linkage studies of MH are...
10.
Cruickshank R, Spencer A, Ellis F
Anaesthesia
. 1996 Dec;
51(12):1097-101.
PMID: 9038439
In a double-blind randomised study, two dosing regimens for controlled-release morphine tablets were compared against placebo to ascertain the extent of prophylactic postoperative pain control in 51 women undergoing abdominal...